680 related articles for article (PubMed ID: 26781188)
1. WNT pathway inhibitor pyrvinium pamoate inhibits the self-renewal and metastasis of breast cancer stem cells.
Xu L; Zhang L; Hu C; Liang S; Fei X; Yan N; Zhang Y; Zhang F
Int J Oncol; 2016 Mar; 48(3):1175-86. PubMed ID: 26781188
[TBL] [Abstract][Full Text] [Related]
2. Lentivirus-mediated shRNA targeting Nanog inhibits cell proliferation and attenuates cancer stem cell activities in breast cancer.
Hu C; Xu L; Liang S; Zhang Z; Zhang Y; Zhang F
J Drug Target; 2016; 24(5):422-32. PubMed ID: 26339994
[TBL] [Abstract][Full Text] [Related]
3. Combinatorial TGF-β attenuation with paclitaxel inhibits the epithelial-to-mesenchymal transition and breast cancer stem-like cells.
Park SY; Kim MJ; Park SA; Kim JS; Min KN; Kim DK; Lim W; Nam JS; Sheen YY
Oncotarget; 2015 Nov; 6(35):37526-43. PubMed ID: 26462028
[TBL] [Abstract][Full Text] [Related]
4. The antihelmintic drug pyrvinium pamoate targets aggressive breast cancer.
Xu W; Lacerda L; Debeb BG; Atkinson RL; Solley TN; Li L; Orton D; McMurray JS; Hang BI; Lee E; Klopp AH; Ueno NT; Reuben JM; Krishnamurthy S; Woodward WA
PLoS One; 2013; 8(8):e71508. PubMed ID: 24013655
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of SDF-1 activates the NF-κB pathway to induce epithelial to mesenchymal transition and cancer stem cell-like phenotypes of breast cancer cells.
Kong L; Guo S; Liu C; Zhao Y; Feng C; Liu Y; Wang T; Li C
Int J Oncol; 2016 Mar; 48(3):1085-94. PubMed ID: 26782945
[TBL] [Abstract][Full Text] [Related]
6. Loss of Mel-18 enhances breast cancer stem cell activity and tumorigenicity through activating Notch signaling mediated by the Wnt/TCF pathway.
Won HY; Lee JY; Shin DH; Park JH; Nam JS; Kim HC; Kong G
FASEB J; 2012 Dec; 26(12):5002-13. PubMed ID: 22954590
[TBL] [Abstract][Full Text] [Related]
7. A novel oncogenic role of inositol phosphatase SHIP2 in ER-negative breast cancer stem cells: involvement of JNK/vimentin activation.
Fu CH; Lin RJ; Yu J; Chang WW; Liao GS; Chang WY; Tseng LM; Tsai YF; Yu JC; Yu AL
Stem Cells; 2014 Aug; 32(8):2048-60. PubMed ID: 24802135
[TBL] [Abstract][Full Text] [Related]
8. Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT.
Hu C; Li M; Guo T; Wang S; Huang W; Yang K; Liao Z; Wang J; Zhang F; Wang H
Phytomedicine; 2019 May; 58():152740. PubMed ID: 31005718
[TBL] [Abstract][Full Text] [Related]
9. Wnt blockers inhibit the proliferation of lung cancer stem cells.
Zhang X; Lou Y; Zheng X; Wang H; Sun J; Dong Q; Han B
Drug Des Devel Ther; 2015; 9():2399-407. PubMed ID: 25960639
[TBL] [Abstract][Full Text] [Related]
10. The Hedgehog signalling pathway mediates drug response of MCF-7 mammosphere cells in breast cancer patients.
He M; Fu Y; Yan Y; Xiao Q; Wu H; Yao W; Zhao H; Zhao L; Jiang Q; Yu Z; Jin F; Mi X; Wang E; Cui Z; Fu L; Chen J; Wei M
Clin Sci (Lond); 2015 Nov; 129(9):809-22. PubMed ID: 26201092
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of metformin at low concentration on epithelial-mesenchymal transition of CD44(+)CD117(+) ovarian cancer stem cells.
Zhang R; Zhang P; Wang H; Hou D; Li W; Xiao G; Li C
Stem Cell Res Ther; 2015 Dec; 6():262. PubMed ID: 26718286
[TBL] [Abstract][Full Text] [Related]
12. [Tricostantin A inhibits self-renewal of breast cancer stem cells in vitro].
Peng L; Li FX; Shao WF; Xiong JB
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Oct; 33(10):1421-6. PubMed ID: 24144739
[TBL] [Abstract][Full Text] [Related]
13. Hsp27 participates in the maintenance of breast cancer stem cells through regulation of epithelial-mesenchymal transition and nuclear factor-κB.
Wei L; Liu TT; Wang HH; Hong HM; Yu AL; Feng HP; Chang WW
Breast Cancer Res; 2011 Oct; 13(5):R101. PubMed ID: 22023707
[TBL] [Abstract][Full Text] [Related]
14. Endothelial cells provide a notch-dependent pro-tumoral niche for enhancing breast cancer survival, stemness and pro-metastatic properties.
Ghiabi P; Jiang J; Pasquier J; Maleki M; Abu-Kaoud N; Rafii S; Rafii A
PLoS One; 2014; 9(11):e112424. PubMed ID: 25380486
[TBL] [Abstract][Full Text] [Related]
15. Effect of Melatonin in Epithelial Mesenchymal Transition Markers and Invasive Properties of Breast Cancer Stem Cells of Canine and Human Cell Lines.
Gonçalves Ndo N; Colombo J; Lopes JR; Gelaleti GB; Moschetta MG; Sonehara NM; Hellmén E; Zanon Cde F; Oliani SM; Zuccari DA
PLoS One; 2016; 11(3):e0150407. PubMed ID: 26934679
[TBL] [Abstract][Full Text] [Related]
16. Hydroxytyrosol inhibits cancer stem cells and the metastatic capacity of triple-negative breast cancer cell lines by the simultaneous targeting of epithelial-to-mesenchymal transition, Wnt/β-catenin and TGFβ signaling pathways.
Cruz-Lozano M; González-González A; Marchal JA; Muñoz-Muela E; Molina MP; Cara FE; Brown AM; García-Rivas G; Hernández-Brenes C; Lorente JA; Sanchez-Rovira P; Chang JC; Granados-Principal S
Eur J Nutr; 2019 Dec; 58(8):3207-3219. PubMed ID: 30460610
[TBL] [Abstract][Full Text] [Related]
17. Apatinib Inhibits Stem Properties and Malignant Biological Behaviors of Breast Cancer Stem Cells by Blocking Wnt/β-catenin Signal Pathway through Downregulating LncRNA ROR.
Jiang B; Zhu H; Tang L; Gao T; Zhou Y; Gong F; Tan Y; Xie L; Wu X; Li Y
Anticancer Agents Med Chem; 2022; 22(9):1723-1734. PubMed ID: 33845750
[TBL] [Abstract][Full Text] [Related]
18. 3,6-dihydroxyflavone suppresses the epithelial-mesenchymal transition in breast cancer cells by inhibiting the Notch signaling pathway.
Chen J; Chang H; Peng X; Gu Y; Yi L; Zhang Q; Zhu J; Mi M
Sci Rep; 2016 Jun; 6():28858. PubMed ID: 27345219
[TBL] [Abstract][Full Text] [Related]
19. Cancer stemness in bone marrow micrometastases of human breast cancer.
Kuo MC; Kothari AN; Kuo PC; Mi Z
Surgery; 2018 Feb; 163(2):330-335. PubMed ID: 28988933
[TBL] [Abstract][Full Text] [Related]
20. Selective mode of action of plumbagin through BRCA1 deficient breast cancer stem cells.
Somasundaram V; Hemalatha SK; Pal K; Sinha S; Nair AS; Mukhopadhyay D; Srinivas P
BMC Cancer; 2016 May; 16():336. PubMed ID: 27229859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]